๐๐ก๐ฒ ๐ ๐ซ๐๐ง๐๐ ๐ข๐ฌ ๐๐๐๐๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ข๐ ๐ข๐ญ๐๐ฅ ๐๐๐๐ฅ๐ญ๐ก ๐๐๐ข๐ฆ๐๐ฎ๐ซ๐ฌ๐๐ฆ๐๐ง๐ญ?
France has the most developed approach to reimbursement for digital health in Europeโan ongoing priority recognized in the โPlan France 2030.โ
๐ Reimbursement Pathways in France
Several pathways exist for digital health reimbursement, each tailored to different technologies and needs:
- ๐น Temporary Reimbursement for Digital Therapeutics (DTx) & Telemonitoring during evidence development, before transitioning to permanent reimbursement (PECAN).
- ๐น Remote Monitoring pathways:
- โ Pre-defined category (generic) solutions.
- โ New indications requiring approval (LATM).
- ๐น Permanent Reimbursement for DTx under LPPR (Liste des Produits et Prestations Remboursables).
Each pathway has unique characteristics depending on the type of technology and its intended use.
๐ Plan France 2030: A Digital Health Powerhouse
The French government has committed โฌ718.4 million through Plan France 2030 to accelerate digital health adoption. This investment is fostering a thriving ecosystem that supports projects shifting healthcare towards more preventive and personalized solutions.
These efforts are transforming France into a digital health eldorado, attracting innovators and investors alike. From AI-powered diagnostic tools to patient-centric mobile applications, the French digital health landscape is evolving rapidly.
๐ฌ Want to Learn More About Franceโs Digital Health Revolution?
Join our upcoming webinar on March 20th, where we'll dive deep into how you can leverage these pathways for your technology.
๐ Register Now